245 related articles for article (PubMed ID: 35332817)
21. Optic neuritis after ocular trauma in anti-aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder.
Akaishi T; Himori N; Takeshita T; Fujihara K; Misu T; Takahashi T; Fujimori J; Ishii T; Aoki M; Nakazawa T; Nakashima I
Brain Behav; 2021 May; 11(5):e02083. PubMed ID: 33591639
[TBL] [Abstract][Full Text] [Related]
22. Aquaporin-4-antibody-positive Neuromyelitis Optica Spectrum Disorder in a Patient with Charcot-Marie-Tooth Disease Type 1A.
Hamada Y; Takahashi K; Kanbayashi T; Hatanaka Y; Kobayashi S; Sonoo M
Intern Med; 2021 May; 60(10):1611-1614. PubMed ID: 33361678
[TBL] [Abstract][Full Text] [Related]
23. Therapeutic options in neuromyelitis optica spectrum disorders.
Kitley J; Palace J
Expert Rev Neurother; 2016; 16(3):319-29. PubMed ID: 26840802
[TBL] [Abstract][Full Text] [Related]
24. Prevalence of anti-aquaporin 4 antibody in a diagnostic cohort of patients being investigated for possible neuromyelitis optica spectrum disorder in Western Australia.
Fabis-Pedrini MJ; Bundell C; Wee CK; Lucas M; McLean-Tooke A; Mastaglia FL; Carroll WM; Kermode AG
J Neuroimmunol; 2018 Nov; 324():76-80. PubMed ID: 30248527
[TBL] [Abstract][Full Text] [Related]
25. Short myelitis lesions in aquaporin-4-IgG-positive neuromyelitis optica spectrum disorders.
Flanagan EP; Weinshenker BG; Krecke KN; Lennon VA; Lucchinetti CF; McKeon A; Wingerchuk DM; Shuster EA; Jiao Y; Horta ES; Pittock SJ
JAMA Neurol; 2015 Jan; 72(1):81-7. PubMed ID: 25384099
[TBL] [Abstract][Full Text] [Related]
26. Aquaporin-4-IgG positive neuromyelitis optica spectrum disorder and systemic autoimmune diseases overlap syndrome: a single-center experience.
Martín-Nares E; Hernandez-Molina G; Fragoso-Loyo H
Lupus; 2019 Oct; 28(11):1302-1311. PubMed ID: 31566079
[TBL] [Abstract][Full Text] [Related]
27. Frequency and syndrome specificity of antibodies to aquaporin-4 in neurological patients with rheumatic disorders.
Jarius S; Jacobi C; de Seze J; Zephir H; Paul F; Franciotta D; Rommer P; Mader S; Kleiter I; Reindl M; Akman-Demir G; Seifert-Held T; Kristoferitsch W; Melms A; Wandinger KP; Wildemann B
Mult Scler; 2011 Sep; 17(9):1067-73. PubMed ID: 21543553
[TBL] [Abstract][Full Text] [Related]
28. Should Aquaporin-4 Antibody Test Be Performed in all Patients With Isolated Optic Neuritis?
Siantar RG; Ibrahim FNI; Htoon HM; Tow SLC; Goh KY; Loo JL; Lim SA; Milea D; Tien MCH; Chen Z; Yeo T; Chai JYH; Singhal S; Chin CF; Tan K
J Neuroophthalmol; 2022 Dec; 42(4):454-461. PubMed ID: 36255079
[TBL] [Abstract][Full Text] [Related]
29. ABCB1 gene polymorphisms impact the effect of high-dose intravenous methylprednisolone therapy on optic neuritis associated with AQP4-IgG-positive neuromyelitis optica spectrum disorder.
Dai Y; Ni S; Wu F; Guo S; Zhao X; Wang J
J Clin Pharm Ther; 2022 Sep; 47(9):1379-1387. PubMed ID: 35488449
[TBL] [Abstract][Full Text] [Related]
30. Anti-aquaporin-1 autoantibodies in patients with neuromyelitis optica spectrum disorders.
Tzartos JS; Stergiou C; Kilidireas K; Zisimopoulou P; Thomaidis T; Tzartos SJ
PLoS One; 2013; 8(9):e74773. PubMed ID: 24086369
[TBL] [Abstract][Full Text] [Related]
31. Clinical features and sera anti-aquaporin 4 antibody positivity in patients with demyelinating disorders of the central nervous system from Tianjin, China.
Yang CS; Zhang DQ; Wang JH; Jin WN; Li MS; Liu J; Zhang CJ; Li T; Shi FD; Yang L
CNS Neurosci Ther; 2014 Jan; 20(1):32-9. PubMed ID: 23890015
[TBL] [Abstract][Full Text] [Related]
32. Neuromyelitis optica spectrum disorders: from pathophysiology to therapeutic strategies.
Carnero Contentti E; Correale J
J Neuroinflammation; 2021 Sep; 18(1):208. PubMed ID: 34530847
[TBL] [Abstract][Full Text] [Related]
33. Aquaporin-4 Serostatus and Visual Outcomes in Clinically Isolated Acute Optic Neuritis.
Carnero Contentti E; De Virgiliis M; Hryb JP; Gomez A; Morales S; Celso J; Leguizamón F; Chiganer E; Di Pace JL; Lessa C; Perassolo M
J Neuroophthalmol; 2019 Jun; 39(2):165-169. PubMed ID: 30004999
[TBL] [Abstract][Full Text] [Related]
34. Longitudinally extensive transverse myelitis with and without aquaporin 4 antibodies.
Kitley J; Leite MI; Küker W; Quaghebeur G; George J; Waters P; Woodhall M; Vincent A; Palace J
JAMA Neurol; 2013 Nov; 70(11):1375-81. PubMed ID: 23999580
[TBL] [Abstract][Full Text] [Related]
35. Aquaporin-4 antibodies (NMO-IgG) as a serological marker of neuromyelitis optica: a critical review of the literature.
Jarius S; Wildemann B
Brain Pathol; 2013 Nov; 23(6):661-83. PubMed ID: 24118483
[TBL] [Abstract][Full Text] [Related]
36. Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study.
Kitley J; Waters P; Woodhall M; Leite MI; Murchison A; George J; Küker W; Chandratre S; Vincent A; Palace J
JAMA Neurol; 2014 Mar; 71(3):276-83. PubMed ID: 24425068
[TBL] [Abstract][Full Text] [Related]
37. Neuromyelitis Optica Spectrum Disorders.
Akaishi T; Nakashima I; Sato DK; Takahashi T; Fujihara K
Neuroimaging Clin N Am; 2017 May; 27(2):251-265. PubMed ID: 28391784
[TBL] [Abstract][Full Text] [Related]
38. Different clinical phenotypes of AQP4-IgG positive NMOSD in two first degree relatives.
Ssemmanda S; Musubire AK
BMC Neurol; 2023 Sep; 23(1):315. PubMed ID: 37667215
[TBL] [Abstract][Full Text] [Related]
39. Structural and visual functional deficits in a rat model of neuromyelitis optica spectrum disorders related optic neuritis.
Zhang Y; Bao Y; Qiu W; Peng L; Fang L; Xu Y; Yang H
Exp Eye Res; 2018 Oct; 175():124-132. PubMed ID: 29913164
[TBL] [Abstract][Full Text] [Related]
40. Clinicoradiological comparative study of Aquaporin-4-IgG seropositive neuromyelitis optica spectrum disorder (NMOSD) and MOG antibody associated disease (MOGAD): A prospective observational study and review of literature.
Nagireddy RBR; Kumar A; Singh VK; Prasad R; Pathak A; Chaurasia RN; Mishra VN; Joshi D
J Neuroimmunol; 2021 Dec; 361():577742. PubMed ID: 34655992
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]